Stockscreener 앱 받기
1.81
3.21%
-0.06
전일 마감가:
$1.87
열려 있는:
$1.89
하루 거래량:
163.44K
Relative Volume:
0.45
시가총액:
$138.16M
수익:
$4.29M
순이익/손실:
$-104.03M
주가수익비율:
-0.9195
EPS:
-1.9685
순현금흐름:
$-50.65M
1주 성능:
-6.22%
1개월 성능:
+20.67%
6개월 성능:
-12.98%
1년 성능:
+22.71%
1일 변동 폭
$1.75
$1.89
1주일 범위
$1.75
$1.99
52주 변동 폭
$1.09
$4.1907
Cibus Inc Stock (CBUS) Company Profile
명칭
Cibus Inc
전화
(858) 450-0008
주소
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.81 | 138.16M | 4.29M | -104.03M | -50.65M | -1.9685 |
VRTX
Vertex Pharmaceuticals Inc
|
496.07 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
784.36 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
865.04 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
205.15 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
348.27 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-29 | 개시 | Alliance Global Partners | Buy |
| 2024-07-19 | 재개 | Canaccord Genuity | Buy |
| 2023-10-09 | 개시 | H.C. Wainwright | Buy |
| 2023-07-19 | 재개 | Canaccord Genuity | Buy |
Cibus Inc 주식(CBUS)의 최신 뉴스
Cibus Market Sentiment - Benzinga
Cibus Inc (CBUS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
888,124 Shares in Cibus, Inc. $CBUS Bought by Weiss Asset Management LP - MarketBeat
Cibus Inc (CBUS) Cash Flow - TradingKey
Cibus Inc (CBUS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cibus Inc (CBUS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CBUS|Cibus Inc|Price:1.700|Chg%:-0.080 - TradingKey
Cibus, Inc. Revenue Breakdown – NASDAQ:CBUS - TradingView
TradingKey - TradingKey
Cibus (NASDAQ:CBUS) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
CBUS|Cibus Inc|Price:1.690|Chg%:-0.090 - TradingKey
Cibus Inc (CBUS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cibus Inc (CBUS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CBUS|Cibus Inc|Price:1.800|Chg%:-0.010 - TradingKey
Cibus Inc (CBUS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CBUS|Cibus Inc|Price:1.800|Chg%:+0.100 - TradingKey
Cibus Inc (CBUS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cibus (NASDAQ:CBUS) Trading 5.7% HigherHere's Why - MarketBeat
Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection - Yahoo Finance
Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection – Downloadable Initiation Report - Yahoo Finance
Cibus Inc. (CBUS) Surges Over 12% as Momentum Builds at Key LevelsGrowth Stock Picks - dars.gov.et
Cibus (CBUS) Welcomes Landmark EU Crop Breeding Decision - Yahoo Finance
Hagerstown Rotary distributes $55K to local nonprofits - The Herald-Mail
CBUS Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Double-Digit GainsEPS Consistency Score - DonanımHaber
Price to book forward of Cibus, Inc. – NASDAQ:CBUS - TradingView
CBUS Q1 2026 Earnings: Narrower-Than-Expected Loss Amid Ongoing Operational TransitionReturn On Equity - Bölüm Sonu Canavarı
CBUSCibus Inc Options - Finviz
Enterprise value to EBIT forward of Cibus, Inc. – NASDAQ:CBUS - TradingView
Cibus Inc. (CBUS) Edges Higher at $1.36 as Buyers Test Resistance Near $1.43Composite Profile - dars.gov.et
Enterprise value to EBITDA forward of Cibus, Inc. – NASDAQ:CBUS - TradingView
CBUS Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Cibus, Inc. – NASDAQ:CBUS - TradingView
Cibus, Inc. Class A Actuals & Estimates (NASDAQ:CBUS) - TradingView
Price to earnings forward of Cibus, Inc. – NASDAQ:CBUS - TradingView
Price to sales forward of Cibus, Inc. – NASDAQ:CBUS - TradingView
CBUS Q1 2026 Earnings: Narrow EPS Beat Amid Zero RevenueCFO Commentary Report - dars.gov.et
Cibus Inc (CBUS) Institutional Confidence - TradingKey
Cibus Inc (CBUS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus - The Manila Times
Europe opens fast lane for non-GMO crops; Cibus traits expected to fit - Stock Titan
Cibus Inc. (CBUS) Slides 1.6% as Stock Tests Key Support Near $1.17Merger Arbitrage - newsline.com
CBUS Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost DisciplineEarnings Volatility Report - DonanımHaber
Cibus names board member Craig Wichner as new CEO - MSN
Cibus (CBUS) CEO receives 894K RSUs and 1.05M stock options grant - Stock Titan
Cibus Inc. (CBUS) Slides 1.63% as Stock Tests Key Support at $1.15Range Breakout - dars.gov.et
Cibus, Inc. Appoints Craig Wichner as CEO to Lead Next Phase of Growth and Innovation in Agricultural Biotechnology - Minichart
Cibus Resets Leadership and Board to Drive Commercialization - TipRanks
Cibus (NASDAQ: CBUS) taps Farmland LP founder Craig Wichner as CEO - Stock Titan
Cibus Names Board Member Craig Wichner as CEO - Moomoo
Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation - The Manila Times
Cibus appoints Craig Wichner as chief executive officer By Investing.com - Investing.com Australia
Cibus Inc (CBUS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.84%
0.86%
자본화:
|
볼륨(24시간):